During the past decade, Guy's & St. Thomas Cancer Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Guy's & St. Thomas Cancer Centre" are "Non-small Cell Lung Cancer" (1 trials) and "Ovarian Neoplasms" (1 trials). Many other conditions were trialed in "Guy's & St. Thomas Cancer Centre" in a lesser frequency.

Most popular intervention types in "Guy's & St. Thomas Cancer Centre" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Liposomal Doxorubicin" (1 trials), "Telcyta" (1 trials) and "bexarotene" (1 trials). Other intervention names were less common.

The vast majority of trials in "Guy's & St. Thomas Cancer Centre" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Guy's & St. Thomas Cancer Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Guy's & St. Thomas Cancer Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Guy's & St. Thomas Cancer Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".